Your browser doesn't support javascript.
loading
Impact of an automated, remote monitoring and coaching intervention in reducing hospice cancer family caregiving burden: A multisite randomized controlled trial.
Mooney, Kathi H; Coombs, Lorinda A; Whisenant, Meagan S; Wilson, Christina M; Moraitis, Ann Marie; Steinbach, Mary N; Sloss, Elizabeth A; Lloyd, Jennifer L E; Alekhina, Natalya; Berry, Patricia H; Kang, Youjeong; Iacob, Eli; Donaldson, Gary W.
Affiliation
  • Mooney KH; Huntsman Cancer Institute, Salt Lake City, Utah, USA.
  • Coombs LA; University of Utah, Salt Lake City, Utah, USA.
  • Whisenant MS; University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA.
  • Wilson CM; UT Health Science Center at Texas, Houston, Texas, USA.
  • Moraitis AM; University of Alabama Birmingham, Birmingham, Alabama, USA.
  • Steinbach MN; University of Utah, Salt Lake City, Utah, USA.
  • Sloss EA; Huntsman Cancer Institute, Salt Lake City, Utah, USA.
  • Lloyd JLE; University of Utah, Salt Lake City, Utah, USA.
  • Alekhina N; University of Utah, Salt Lake City, Utah, USA.
  • Berry PH; Huntsman Cancer Institute, Salt Lake City, Utah, USA.
  • Kang Y; University of Utah, Salt Lake City, Utah, USA.
  • Iacob E; University of Utah, Salt Lake City, Utah, USA.
  • Donaldson GW; University of Utah, Salt Lake City, Utah, USA.
Cancer ; 130(7): 1171-1182, 2024 04 01.
Article in En | MEDLINE | ID: mdl-38009953
ABSTRACT

BACKGROUND:

Care for those with life-limiting cancer heavily involves family caregivers who may experience significant physical and emotional burden. The purpose of this study was to test the impact of Symptom Care at Home (SCH), an automated digital family caregiver coaching intervention, during home hospice, when compared to usual hospice care (UC) on the primary outcome of overall caregiver burden. Secondary outcomes included Caregiver Burden at weeks 1 and 8, Mood and Vitality subscales, overall moderate-to-severe caregiving symptoms, and sixth month spouse/partner bereavement outcomes.

METHODS:

Using a randomized, multisite, nonblinded controlled trial, 332 cancer family caregivers were enrolled and analyzed (159 SCH vs. 173 UC). Caregivers were primarily White (92%), female (69%), and spouse caregivers (53%). Caregivers provided daily reports on severity levels (0-10 scale) for their anxiety, depressed mood, fatigue, disturbed sleep, and caregiving interference with normal activities. These scores combined constituted the Caregiver Burden primary outcome. Based on reported symptoms, SCH caregivers received automated, tailored coaching about improving their well-being. Reports of moderate-to-severe caregiving symptoms also triggered hospice nurse notification. Secondary outcomes of Mood and Vitality were subcomponents of the Caregiver Burden score. A combined bereavement adjustment tool captured sixth month bereavement.

RESULTS:

The SCH intervention reduced overall Caregiver Burden compared to UC (p < .001), with a 38% reduction at 8 weeks and a medium-to-large effect size (d = .61). SCH caregivers experienced less (p < .001) disruption in both Mood and Vitality. There were higher levels of moderate-to-severe caregiving symptoms overtime in UC (OR, 2.722). All SCH caregivers benefited regardless of caregiver sex, caregiver relationship, age, patient diagnosis and family income. SCH spouse/partner caregivers achieved better sixth month bereavement adjustment than UC (p < .007).

CONCLUSIONS:

The SCH intervention significantly decreased caregiving burden over UC and supports the maintenance of family caregiver mood and vitality throughout caregiving with extended benefit into bereavement.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bereavement / Hospice Care / Mentoring / Hospices / Neoplasms Limits: Female / Humans Language: En Journal: Cancer Year: 2024 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bereavement / Hospice Care / Mentoring / Hospices / Neoplasms Limits: Female / Humans Language: En Journal: Cancer Year: 2024 Document type: Article Affiliation country: United States